NasdaqGM:VCELBiotechs
How Vericel’s (VCEL) Projected 2025 Revenue Growth and GAAP Profitability Streak Will Impact Investors
In January 2026, Vericel Corporation released preliminary unaudited guidance for the fourth quarter and full year 2025, projecting 23% total and MACI revenue growth for the quarter and approximately US$276,000,000 in full-year net revenue, along with GAAP net income profitability for the second consecutive year.
This combination of strong anticipated revenue expansion and back-to-back GAAP profitability highlights improving operating efficiency and growing commercial traction for Vericel’s...